![](https://ckd-otto.b-cdn.net/wp-content/uploads/2024/01/LOGO-FIX.jpeg)
History
Milestones
September – 2015
Company establishment in Jakarta, Indonesia
July – 2016
Factory ground breaking ceremony (building production facilities for lyophilized powder injection and liquid injection)
September – 2016
Starting sales & marketing activities for importation of oncology and immunosuppressant products from CKD, South Korea
December – 2017
Completion of manufacturing construction in Cikarang, Indonesia
September – 2018
Obtaining GMP (Good Manufacturing Practice) certificate from BPOM (Indonesian FDA)
February – 2019
Obtaining Halal certificate from MUI (Indonesian Council of Ulama) with excellent category
July – 2019
Grand opening ceremony and manufacture inauguration with Kemenkes (Indonesian MoH)
First launch of targeted oral oncology product, Leukivec
August – 2020
Obtaining TKDN (Level of Domestic Content ) from Kemenperin (Indonesian MoI)
January – 2021
Starting Local CMO (Contract Manufacturing Organization) business
March – 2021
Signing the contract of exportation with one MENA Country
October – 2021
First exportation shipment to one MENA Country
August 2022
Inspected by SFDA (Saudi Food and Drug Authority) for GMPÂ Compliances
September – 2022
Obtaining BMP (Company Benefit Weight) from Kemenperin (Indonesian MOI)
Obtaining ISO 14001:2015 (Environmental Management System) from SIS (Syndicate of International System) Certifications
Progress of Cytotoxic injection registration in ASEAN and GCC countries
December – 2023
Moving our HQ location to Sudirman Street, central business district in Jakarta
![](https://ckd-otto.b-cdn.net/wp-content/uploads/2023/12/CKD-OTTO-127-1-1-1024x344.png)
Our Shareholder
Meet CKD OTTO Shareholders
Key partners who support our commitment to pharmaceutical innovation and advances in cancer treatment.
Video Gallery
Historical Journeys
Playlist
5 Videos